Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Ruthenium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.